A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation.
- 15 October 1996
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 93 (21) , 11321-11326
- https://doi.org/10.1073/pnas.93.21.11321
Abstract
Human cytomegalovirus (CMV) replication begins with the expression of two regulatory proteins, IE1(491aa) and IE2(579aa), produced from differentially spliced transcripts under control of the ie1/ie2 promoter-enhancer. A deletion mutation removing all 406 IE1(491aa)-specific amino acids was engineered into the viral genome and this mutant (RC303 delta Acc) was propagated on an IE1(491aa)-expressing human fibroblast cell line (ihfie1.3). RC303 delta Acc failed to replicate on normal human fibroblasts at low multiplicities of infection (mois). At mois > 3 plaque-forming units per cell, virus replication and production of progeny were comparable to wild type. However, at mois between 0.01 and 1, mutant virus replicated slowly on normal fibroblasts, a pattern that suggested initiation of productive infection required multiple hits. Replication of RC303 delta Acc correlated with the ability to express IE2(579aa), consistent with a role for IE1(491aa) in positive autoregulation of the ie1/ie2 promoter-enhancer and with data suggesting that virion transactivators compensate for the lack of IE1(491aa) under high moi conditions. ie1-deficient CMV should be completely avirulent, suggesting its utility as a gene therapy vector for hematopoietic progenitors that are normal sites of CMV latency.Keywords
This publication has 21 references indexed in Scilit:
- Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals.Proceedings of the National Academy of Sciences, 1996
- Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors.1995
- Cell Type-specific Induction of the Major Immediate Early Enhancer of Human Cytomegalovirus by Cyclic AMPJournal of General Virology, 1990
- Expression of the acidic nuclear immediate-early protein (IE1) of human cytomegalovirus in stable cell lines and its preferential association with metaphase chromosomesVirology, 1989
- Protective Effects of Towne Cytomegalovirus Vaccine Against Low-Passage Cytomegalovirus Administered as a ChallengeThe Journal of Infectious Diseases, 1989
- Complementation of a Herpes Simplex Virus Type 1 Vmw110 Deletion Mutant by Human CytomegalovirusJournal of General Virology, 1989
- Isolation and Characterization of a Herpes Simplex Virus Type 1 Mutant Containing a Deletion within the Gene Encoding the Immediate Early Polypeptide Vmw110Journal of General Virology, 1986
- A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirusCell, 1985
- TOWNE-VACCINE-INDUCED PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER RENAL TRANSPLANTSThe Lancet, 1984
- Promoter-regulatory region of the major immediate early gene of human cytomegalovirus.Proceedings of the National Academy of Sciences, 1984